Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2025-12-25 @ 5:21 PM
NCT ID: NCT02318303
Description: None
Frequency Threshold: 5
Time Frame: AEs and SAEs were collected from the time of signing the informed consent form until the follow-up contact
Study: NCT02318303
Study Brief: To Study GSP 301 in Patients With Seasonal Allergic Rhinitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
GSP 301 Placebo NS GSP 301 placebo NS administered as 2 sprays/nostril None None 0 159 0 159 View
GSP 301-1 NS (QD) GSP 301-1 NS (QD) administered as 2 sprays/nostril None None 1 158 0 158 View
Mometasone Furoate-1 NS (QD) Mometasone furoate-1 NS (QD) administered as 2 sprays/nostril None None 0 160 0 160 View
Olopatadine HCl-1 NS (QD) Olopatadine HCl-1 NS (QD) administered as 2 sprays/nostril None None 0 158 0 158 View
GSP 301-2 NS (BID) GSP 301-2 NS (BID) administered as 2 sprays/nostril. None None 0 157 0 157 View
Mometasone Furoate-2 NS (BID) Mometasone furoate-2 NS (BID) administered as 2 sprays/nostril None None 0 159 0 159 View
Olopatadine HCl-2 NS (BID) Olopatadine HCl-2 NS (BID) administered as 2 sprays/nostril None None 0 160 0 160 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Gastrointestinal ulcer and Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 14.1 View
Other Events(If Any):